The US Supreme Court ruled Tuesday that generic drug makers can challenge big-name pharmaceutical firms in court to stop them from broadening the scope of their patent descriptions.
Apr 18, 2012
0
0
To beat the coronavirus pandemic, countries need to collaborate. We need the best possible science to develop vaccines and drugs, and to test, track and contain the virus. If we've learned anything from the rapid global spread ...
Jul 3, 2020
1
3
Radiation, used to treat half of all cancer patients, can be measured during treatment for the first time with precise 3D imaging developed at the University of Michigan.
Jan 3, 2023
0
60
A new diagnostic technology may significantly improve early detection and treatment of cancer and other diseases. Via a simple blood test the method can potentially diagnose diseases such as cancer at an early stage, enable ...
Jan 5, 2015
0
99
(AP) -- India effectively ended Bayer's monopoly on a patented cancer drug Monday, licensing a much cheaper generic under a unique law aimed at keeping costs affordable.
Mar 12, 2012
0
1
French drugmaker Sanofi is buying the rights to seek approval for a version of the erectile dysfunction drug Cialis that customers would be able to buy without a doctor's prescription.
May 28, 2014
0
0
Indian generics giant Cipla says it has scored a "landmark" court win in a patent challenge launched by Switzerland's Roche Holding over the Mumbai firm's version of a lung-cancer drug.
Sep 8, 2012
2
0
With the expiration in January of the patent on Gleevec, the drug that 15 years ago changed chronic myeloid leukemia (CML) from a death sentence to a treatable illness, insurance companies and patients have the opportunity ...
Mar 15, 2016
0
2
The COVID-19 treatment remdesivir dominated hospital drug spending in 2021, accounting for nearly 10% of all pharmaceutical expenses and outpacing the next three drugs combined, according to the National Trends in Prescription ...
Apr 6, 2022
0
15
Biotechnology industry officials are warning that a US Supreme Court ruling on patent rights this week could have a chilling effect on the development of personalized medicine.
Mar 21, 2012
1
0
